Alexander F Glick1, Suzy Tomopoulos2, Arthur H Fierman2, Anne Elixhauser3, Leonardo Trasande4. 1. Department of Pediatrics, New York University (NYU) Langone Health/Bellevue Hospital Center (AF Glick, S Tomopoulos, AH Fierman, and L Trasande). Electronic address: alexander.glick@nyumc.org. 2. Department of Pediatrics, New York University (NYU) Langone Health/Bellevue Hospital Center (AF Glick, S Tomopoulos, AH Fierman, and L Trasande). 3. Agency for Healthcare Research and Quality (A Elixhauser), Rockville, Md. 4. Department of Pediatrics, New York University (NYU) Langone Health/Bellevue Hospital Center (AF Glick, S Tomopoulos, AH Fierman, and L Trasande); Departments of Environmental Medicine and Population Health, NYU School of Medicine (L Trasande); NYU Wagner School of Public Service (L Trasande); NYU College of Global Public Health (L Trasande).
Abstract
OBJECTIVE: Pneumonia is a leading cause of pediatric admissions. Although air pollutants are associated with poor outcomes, few national studies have examined associations between pollutant levels and inpatient pediatric pneumonia outcomes. We examined the relationship between ozone (O3) and fine particulate matter with a diameter ≤2.5 µm (PM2.5) and outcomes related to disease severity. METHODS: In this cross-sectional study, we obtained discharge data from the 2007 to 2008 Nationwide Inpatient Sample and pollution data from the Air Quality System. Patients ≤18years with a principal diagnosis of pneumonia were included. Discharge data were linked to O3 and PM2.5 levels (predictors) from the patient's ZIP Code (not publicly available) from day of admission. Outcomes were mortality, intubation, length of stay (LOS), and total costs. We calculated weighted national estimates and performed multivariable analyses adjusting for sociodemographic and hospital factors. RESULTS: There were a total of 57,972 (278,871 weighted) subjects. Median PM2.5 level was 9.5 (interquartile range [IQR] 6.8-13.4) µg/m3. Median O3 level was 35.6 (IQR 28.2-45.2) parts per billion. Mortality was 0.1%; 0.75% of patients were intubated. Median LOS was 2 (IQR 2-4) days. Median costs were $3089 (IQR $2023-$5177). Greater levels of PM2.5 and O3 were associated with mortality, longer LOS, and greater costs. Greater O3 levels were associated with increased odds of intubation. CONCLUSIONS: Greater levels of O3 and PM2.5 were associated with more severe presentations of pneumonia. Future work should examine these relationships in more recent years and over a longer time period.
OBJECTIVE:Pneumonia is a leading cause of pediatric admissions. Although air pollutants are associated with poor outcomes, few national studies have examined associations between pollutant levels and inpatient pediatric pneumonia outcomes. We examined the relationship between ozone (O3) and fine particulate matter with a diameter ≤2.5 µm (PM2.5) and outcomes related to disease severity. METHODS: In this cross-sectional study, we obtained discharge data from the 2007 to 2008 Nationwide Inpatient Sample and pollution data from the Air Quality System. Patients ≤18years with a principal diagnosis of pneumonia were included. Discharge data were linked to O3 and PM2.5 levels (predictors) from the patient's ZIP Code (not publicly available) from day of admission. Outcomes were mortality, intubation, length of stay (LOS), and total costs. We calculated weighted national estimates and performed multivariable analyses adjusting for sociodemographic and hospital factors. RESULTS: There were a total of 57,972 (278,871 weighted) subjects. Median PM2.5 level was 9.5 (interquartile range [IQR] 6.8-13.4) µg/m3. Median O3 level was 35.6 (IQR 28.2-45.2) parts per billion. Mortality was 0.1%; 0.75% of patients were intubated. Median LOS was 2 (IQR 2-4) days. Median costs were $3089 (IQR $2023-$5177). Greater levels of PM2.5 and O3 were associated with mortality, longer LOS, and greater costs. Greater O3 levels were associated with increased odds of intubation. CONCLUSIONS: Greater levels of O3 and PM2.5 were associated with more severe presentations of pneumonia. Future work should examine these relationships in more recent years and over a longer time period.
Authors: Nicole Vargas Patto; Luiz Fernando Costa Nascimento; Katia Cristina C Mantovani; Luciana C P F S Vieira; Demerval S Moreira Journal: Rev Assoc Med Bras (1992) Date: 2016-07 Impact factor: 1.209
Authors: Ron Keren; Xianqun Luan; Russell Localio; Matt Hall; Lisa McLeod; Dingwei Dai; Rajendu Srivastava Journal: Arch Pediatr Adolesc Med Date: 2012-12
Authors: Matthew P Kronman; Adam L Hersh; Rui Feng; Yuan-Shung Huang; Grace E Lee; Samir S Shah Journal: Pediatrics Date: 2011-02-14 Impact factor: 7.124
Authors: Lyndsey A Darrow; Mitchel Klein; W Dana Flanders; James A Mulholland; Paige E Tolbert; Matthew J Strickland Journal: Am J Epidemiol Date: 2014-10-16 Impact factor: 4.897
Authors: Kohei Hasegawa; Hirokazu Toubou; Teruomi Tsukahara; Tetsuo Nomiyama Journal: Int J Environ Res Public Health Date: 2021-04-13 Impact factor: 3.390